Can a healthy endothelium influence the cardiovascular effects of hormone replacement therapy?
Emerging clinical and observational evidences suggest that estrogen confers physiologic benefits that are receptor mediated and depend on the integrity and functional status of the endothelium within the coronary vasculature. In postmenopausal women, estrogen replacement therapy (ERT) and hormone replacement therapy (HRT) regimens can enhance the lipoprotein panel; blunt the expression of numerous cytokines, chemokines, and other proinflammatory mediators of endothelial injury and vascular smooth muscle cell proliferation; up-regulate endothelial nitric oxide synthase activity and nitric oxide production; and augment fibrinolysis potential and vasodilator capacity (diminish arterial resistance). Advancing age and atherosclerotic injury to the vessel wall tend to deplete estrogen receptors, compromise endothelial function, promote thrombus formation, and thus potentially diminish the efficacy of ERT and HRT. Therefore, optimizing the clinical benefits of these regimens in postmenopausal women depends largely on promoting a healthy endothelium through life-style modifications that diminish coronary risk.
Koh
Kwang Kon
KK
Division of Cardiology, Gil Heart Center, Gachon Medical School, 1198 Kuwol-Dong Namdong-Gu, 405-760 Inchon, South Korea. kwangk@ghil.com
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D020249:Hormone Replacement Therapy; D006801:Humans; D008019:Life Style; D017698:Postmenopause; D012307:Risk Factors